FDA Inspection 1203832 — Lulu C. Bravo, MD
The FDA completed an inspection of Lulu C. Bravo, MD on March 10, 2023 in Manila. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 10, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Manila (Philippines)
Additional Details
Clinical Investigator (CI)